Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W W Vale

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
Peptides|January 1, 1988
Growth hormone response to growth hormone-releasing factor in depressionK R Krishnan, A N Manepalli, J C Ritchie, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1993
New technique for quantitation of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonadotropin-releasing hormone antagonistG A McGrath, R J Goncalves, J K Udupa, et al.
Psychopharmacology|March 5, 2002
Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the ratM G Spina, E Merlo-Pich, Y Akwa, et al.
The American Journal of Psychiatry|January 1, 1988
Growth hormone-releasing factor stimulation test in depressionK R Krishnan, A N Manepalli, J C Ritchie, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1991
Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libidoS N Pavlou, K Brewer, M G Farley, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1990
Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonistL Daneshdoost, S N Pavlou, M E Molitch, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptorsT M Reyes, K Lewis, M H Perrin, et al.
The European Journal of Neuroscience|July 31, 2003
The effect of urocortin on ingestive behaviours and brain Fos immunoreactivity in miceP Sinnayah, J R Blair-West, M I McBurnie, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 1998
Displacement of insulin-like growth factors from their binding proteins as a potential treatment for strokeS A Loddick, X J Liu, Z X Lu, et al.
The European Journal of Neuroscience|October 24, 2007
Role of the corticotropin-releasing factor receptor type 2 in the control of food intake in mice: a meal pattern analysisA Tabarin, Y Diz-Chaves, D Consoli, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Peptides|January 1, 1988
Growth hormone response to growth hormone-releasing factor in depressionK R Krishnan, A N Manepalli, J C Ritchie, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1993
New technique for quantitation of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonadotropin-releasing hormone antagonistG A McGrath, R J Goncalves, J K Udupa, et al.
Psychopharmacology|March 5, 2002
Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the ratM G Spina, E Merlo-Pich, Y Akwa, et al.
The American Journal of Psychiatry|January 1, 1988
Growth hormone-releasing factor stimulation test in depressionK R Krishnan, A N Manepalli, J C Ritchie, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1991
Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libidoS N Pavlou, K Brewer, M G Farley, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1990
Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonistL Daneshdoost, S N Pavlou, M E Molitch, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptorsT M Reyes, K Lewis, M H Perrin, et al.
The European Journal of Neuroscience|July 31, 2003
The effect of urocortin on ingestive behaviours and brain Fos immunoreactivity in miceP Sinnayah, J R Blair-West, M I McBurnie, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 1998
Displacement of insulin-like growth factors from their binding proteins as a potential treatment for strokeS A Loddick, X J Liu, Z X Lu, et al.
The European Journal of Neuroscience|October 24, 2007
Role of the corticotropin-releasing factor receptor type 2 in the control of food intake in mice: a meal pattern analysisA Tabarin, Y Diz-Chaves, D Consoli, et al.
Pageof 20